Showing posts with label waria. Show all posts
Showing posts with label waria. Show all posts

Monday, November 16, 2015

A Survey on HIV-Related Health-Seeking Behaviors among Transgender Individuals in Jakarta, Based on the Theory of Planned Behavior

Male-to-female transgender (waria) individuals are at high risk for HIV. This study aims at mapping the psychological determinants of four HIV-related health-seeking behaviors. This knowledge can be used to develop effective interventions to prevent the spread of HIV/AIDS.

The study involved 209 waria from five districts in Jakarta, selected with a cluster sampling procedure. Cross-sectional data were gathered through structured interviews. The four examined behaviors are, visiting sexually transmitted infections (STIs) services regularly, adherence to STI treatment, taking an HIV test and picking up the result of HIV test. For all four behaviors, specific measures of the psychological determinants as defined by the Theory of Planned Behavior were developed: attitudes, subjective norms and perceived behavioral control (PBC). Logistic regression analyses were conducted with these three psychological measures as independent variables and the behaviors as dependent variables.

Of the 209 waria, 20.6 % had never visited STI services in the last 6 months, while 56.5 % had visited the services once or twice, and 23 % had visited the service three or more times. A HIV test had been taken by 90.4 % of the waria, and of those, 64.6 % had picked up the results. About 85 % of the waria who did a HIV test had been tested for HIV one or two times in the last 6 months and 10 % had been tested three to four times. The variance in behaviors that was explained by the concepts defined in the Theory of Planned Behavior ranged from 15 to 70 %; PBC was the most powerful predictor. Furthermore, the results showed that in several cases the relationships of attitudes or subjective norms with the dependent variable were mediated by one or both other independent variables.

The results regarding the prominent role of PBC suggest that interventions should increase waria’s control over the behavior: Engaging in specific desired behaviors should be made easier for them. Besides, waria’s attitudes and subjective norms should be addressed, by education, but possibly also by providing waria with a positive experience with the behavior, for example, by designing a professional and friendly health care system.

Full article at: http://goo.gl/7X00Af

By:  Ciptasari Prabawanti1*, Arie Dijkstra1, Pandu Riono2 and Gagan Hartana3
1Social Psychology Department, Faculty of Behavioral and Social Sciences, University of Groningen, Grote Kruisstraat 2/1 9712 TS, Groningen, The Netherlands
2Population Studies and Biostatistic Department, Faculty of Public Health, University of Indonesia, Kampus UI, Depok 16424, West Java, Indonesia
3Faculty of Psychology, University of Indonesia, Kampus UI, Depok 16424, West Java, Indonesia
 


Wednesday, October 28, 2015

Balancing Benefits & Harm: Chemical Use & Bodily Transformation among Indonesia's Transgender Waria

Members of Indonesia's diverse male-to-female transgender community often describe themselves as waria.Waria do not equate being feminine with being female. They do not want to be women; they aspire to be likewomen. It entails cultivating mannerisms and wearing make-up and women's clothes, shaving one's legs and styling one's hair. But some go further in their practices of self-administered, chemically assisted bodily transformation.

Field research took place in Makassar, the capital city of South Sulawesi; in a smaller town in the regency of Bulukumba on the south coast of Sulawesi; and in the special region of Yogyakarta in Java. Data were collected through repeated in-depth interviews with ten waria youths aged between 18 and 26 in each site; interviews with pharmacists, drug and cosmetics store clerks; three focus group discussions at each site; and participant observation.

Our respondents saw their bodies as ‘projects’ they can manipulate with pharmaceutical products and cosmetics. To lighten their skin, they experimented with different brands of exfoliating liquid, whitening cream, powder, foundation, face soap and skin scrub. To grow breasts and reduce muscle mass, they experimented with different brands and dosages of contraceptive pills and injections in order to get faster, better and longer-lasting results.

Harm reduction programs often neglect chemicals that are not narcotics, not related to sexually transmitted infections, and which are legally and freely available. Safety issues arise when otherwise safe products are used off-label in large quantities. Drug policy-makers are paying insufficient attention to the safety of cosmetics.

Below:  The most popular brands for pills and injections


Table 1

Contraceptive products used to feminize bodies.


ProductManufacturer/licenceContentProduct information
Andalan pillMarketing: DKT IndonesiaEach tablet contains:
0.15 mg Levonolgestrel
0.03 mg Ethinylestradiol
Begin taking on the first day of menstruation
Manufacturer: PT Sydna Farma, Jakarta, IndonesiaIndication: low dosage oral contraceptive for breast-feeding mothers
License: NV Organon, NetherlandsBy prescription only

Marvelon 28 pillMarketing: DKT IndonesiaEach pack consists of 21 large tablets, each containing:
0.150 mg Desogestrel
0.030 mg Ethinylestradiol
No active ingredient in the small tablets
By prescription only
Manufacturer: PT Sydna Farma, Jakarta, Indonesia
License: NV Organon, Netherlands

Trinordiol pillManufacturer: Wyeth, Germany & Republic of IrelandEach light brown tablet contains:
0.03 mg Ethinylestradiol
0.05 mg Levonorgestrel
Synthetic oestrogen and Levonorgestrel is a synthetic form of progesterone
Each white tablet contains:
0.04 mg Ethinylestradiol
0.075 mg Levonorgestrel
Each ochre tablet contains:
0.03 mg Ethinylestradiol
0.125 mg Levonorgestrel
Each 21-day pack contains three types of tablets (six light brown, five white, ten ochre), each with a slightly different hormone dosage

Microgynon pillManufacturer: Schering do Brasil Quimica Farmaceutica Ltda, Sao Paolo, Brazil21 Sugar-coated tablets, each containing:
0.15 mg Levonorgestrel
0.03 mg Ethinylestradiol
7 Sugar-coated tablets, each containing 48.25 mg Lactosa
By prescription only
Importer: PT Bayer Indonesia

Microdiol 30 pillManufacturer and distributor: Kimia Farma IndonesiaEach small tablet contains: 0.150 mg Levonorgestrel 0.030 mg Ethinylestradiol
No active ingredient in the large tablets
By prescription only

Cyclogynon pillMarketing: PT Tunggal Idaman Abdi, IndonesiaEach tablet contains:
0.15 mg Levonorgestrel
0.03 mg Ethinylestradiol
Manufacturer: PT Sunthi Sepuri, Indonesia

Andalan Laktasi pill KBMarketing: DKT IndonesiaEach tablet contains:
0.15 mg Levonorgestrel
0.03 mg Ethinylestradiol
By prescription only
Manufacturer: PT Sydna Farma, Indonesia
License: NV Organon, Netherlands

Andalan contraceptive injectionManufacturer: Harsen, Indonesia, incorporated under DKT IndonesiaEach 1 ml contains: 150 mg Medroxyprogesterone acetateBy prescription only
Sterile suspension of Medroxyprogesterone acetate in water

Cyclofem contraceptive injectionManufacturer: PT Tunggal Idaman Abdi, IndonesiaEach vial contains:
25 mg Medroxyprogesterone acetate
5 mg Estradiol USP sterilized micronized
By prescription only
License: Concept Foundation, Thailand

Below:  A shelf in a market cosmetics stall in Makassar



Below:  Exfoliating products



Full article at: http://goo.gl/22f55E

aDepartment of Anthropology, Faculty of Social and Political Sciences, Hasanuddin University, Makassar, Indonesia
bEuropean Research Council Chemical Youth project, University of Amsterdam, The Netherlands
Corresponding author at: Department of Anthropology, Faculty of Social and Political Sciences, Kampus Unhas Tamalanrea, KM 10, Makassar 90245, Indonesia. Email: moc.oohay@surdiimlilurun
   



On Coba & Cocok: Youth-Led Drug-Experimentation in Eastern Indonesia

The everyday lives of contemporary youths are awash with drugs to boost pleasure, moods, sexual performance, vitality, appearance and health. This paper examines pervasive practices of chemical ‘self-maximization’ from the perspectives of youths themselves. The research for this paper was conducted among male, female and transgender (male to female, so-called waria) sex workers in Makassar, Indonesia. It presents the authors’ ethnographic findings on how these youths experiment with drugs to achieve their desired mental and bodily states: with the painkiller Somadril to feel happy, confident and less reluctant to engage in sex with clients, and contraceptive pills and injectable hormones to feminize their male bodies and to attract customers. Youths are extremely creative in adjusting dosages and mixing substances, with knowledge of the (mostly positive) ‘lived effects’ of drugs spreading through collective experimentation and word of mouth. The paper outlines how these experimental practices differ from those that have become the gold standard in biomedicine...

These ethnographic case studies have revealed the pervasiveness of young sex workers’ desires to feel attractive, happy and confident; how they experiment with different drugs and modes of administration to achieve their desired effects; how experiential knowledge circulates through youth networks; and in the case of Somadril, how youths pool their resources to support their drug habits. Among the key findings is that the authors’ informants ‘try out’, or in their own words ‘coba’, different drugs and techniques to assess the effects on their bodies and minds in what may be called collective youth-led drug experiments.

The experiments involve the ‘off label’ use of prescription pharmaceuticals – that is, for purposes other than their official indication. Such experimentation is not unique to the sex workers at Losari Beach and the waria at Karebosi. The ethnographic fieldwork in Makassar revealed similar patterns of experimentation among other groups of youths. Construction workers mixed energy drinks and potency products; hard-core drug users injected a veritable cocktail into their veins in search of new highs. Students were also found to use Somadril in all kinds of different mixtures, but only on weekends and mainly to enhance sexual pleasure (Hardon, Idrus, and Hymans ).

How does the accumulation of knowledge by youth through trial and error differ from knowledge production in biomedicine? There are five main differences: first, biomedical experiments have pre-defined endpoints. Randomized controlled trials measure the effects of specific chemicals on individual bodies, with the ‘double-blind’ method ensuring that both the subjects of the experiment and those administering it do not know whether the active ingredient or an inert substance is ingested. The group receiving the inert substance is called the control group (Goldstein ). The authors’ informants feel no need for a control group; they evaluate the efficacy of products through self-observation, before and after use.

In the youth-led experiments, the subjects further determine their own desired ‘endpoints’: the development of hard tissue and a base for breasts in the case of contraceptive steroids, feeling confident in the case of Somadril. These ‘endpoints’ emerge out of the sharing of experiential knowledge on what specific drugs can do to alter their minds and bodies. The endpoints are specific to their everyday needs and desires. The wariainformants want to feminize their bodies; freelance sex workers need to be confident to approach clients.
The youth-led experiments differ from biomedical research in how they apprehend a drug's adverse effects. Biomedical researchers a priori define adverse effects and then measure them in trials. Safety and efficacy data are submitted to regulatory agencies, which then weigh the drug's benefits and risks for market approval. It is well known in pharmacology that unexpected side-effects can occur once the drug is used in routine medical practice. In contrast, youths in this study appeared unconcerned about side-effects before trying a drug for the first time. They simply tried it and observed what happens.

A fourth difference between how youth experiment with drugs and biomedical research pertains to how drugs are administered. Drugs in laboratory experiments are tested in isolation, in fixed dosages to allow for the standardized measurement of effects. Youths continuously ‘try out’ different dosages and forms of administration, mixing substances with drinks, foods and other drugs in their quest for better, stronger or faster effects.

Finally, in the biomedical measurement of drug effects, efficacy is situated in the drug's active pharmaceutical content – if substance A is proven to be effective in population B, it is assumed to work identically in population C as well. In assessing the positive and negative effects of substances in their bodies, youths in this study time and again made use of the relational notion of cocok. A drug is cocok if there is a ‘fit’ between the drug and the person taking the drug. A comparable personification of efficacy can be seen in the biomedical discipline of pharmaco-genomics, which shows how drug effects vary depending on individual genetic makeup. Such knowledge, however, still has no place in standard clinical experiments on new drugs which are generally funded by pharmaceutical companies; too much diversity would limit the market for specific drugs....

Full article at: http://goo.gl/lQAlMF

By: Anita Hardon a , * and Nurul Ilmi Idrus b
aAmsterdam Institute for Social Science Research, University of Amsterdam, Amsterdam, the Netherlands
bUniversity of Hasanuddin, Anthropology, Makassar, Indonesia
Corresponding author. Email: ln.avu@nodrah.p.a